A Randomized, Placebo-Controlled, Double-Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite Endpoint

Author: William Hanke C.   Narins Rhoda S.   Brandt Fredric   Cohen Joel L.   Donofrio Lisa M.   Downie Jeanine   Heinz Moritz   Harrington Laura   McDaniel David H.   Nestor Mark   Schlessinger Joel   Schlöbe Andrea   Taub Amy   Weiss Robert A.  

Publisher: Elsevier

ISSN: 1076-0512

Source: Dermatologic Surgery, Vol.39, Iss.6, 2013-06, pp. : 891-899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content